{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"1.330","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"2,035,724,910","primaryexch":"香港交易所","ric":"1521.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":4.0E-4,"inline_upper_strike_price":"","sedol":"BKDQKL5","am":"1.22","iv":"","ew_strike":"","as":"1.280","geographic_focus":null,"incorpin":"開曼群島","etp_baseCur":null,"ew_amt_os":"","bd":"1.250","registrar":"卓佳證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"2,000","update_time":"2025-09-28 00:06:03.0","lo52":"0.500","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"K","base_currency":null,"coupon":"","expiry_date":"","chairman":"李松","underlying_ric":"1521.HK","hi52":"1.870","issuer_name":"方達控股公司","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"1.230","mkt_cap":"2.54","f_aum_hkd":null,"ew_sub_per_to":"","ls":"1.250","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"0.000","aum":"","issued_shares_class_B":null,"vo":"944.00","secondary_listing_flag":false,"listing_date":"2019年5月30日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"方達控股公司","nm_s":"方達控股","sym":"1521","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"Frontage Holdings Corp是一家控股公司。該公司爲制藥和農用化學品公司提供實驗室和相關服務，以及生物等效性臨床和化學服務。該公司有兩個分部。全球實驗室服務部門爲參與藥物開發的客戶提供實驗室測試支持。全球藥物發現與開發服務部門包括藥物開發部門、藥物發現部門和藥品開發部門。其全球實驗室服務涵蓋受監管和非受監管的生物分析（小分子和大分子）、生物標志物、基因組學、制造和控制分析測試以及中央實驗室服務。藥物開發部門包括藥物代謝和藥代動力學、安全性和毒理學。該公司的業務分部包括北美和歐洲以及中國。","op":"1.280","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"生物技術","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"香港銅鑼灣<br/>希慎道33號<br/>利園一期<br/>19樓1920室","pc":"0.00","days_to_expiry":null,"underlying_code":null,"pe":"403.23","eps_ccy":"USD","hdr":false,"launch_date":"","hc":"1.250","isin":"KYG3679P1019","moneyness":""}},"qid":"1759074609725"}
